KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Finished Goods (2016)

AbbVie has reported Finished Goods over the past 5 years, most recently at $556.0 million for Q2 2016.

  • Quarterly Finished Goods rose 16.32% to $556.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $556.0 million through Jun 2016, up 16.32% year-over-year, with the annual reading at $469.0 million for FY2015, 37.54% up from the prior year.
  • Finished Goods was $556.0 million for Q2 2016 at AbbVie, up from $552.0 million in the prior quarter.
  • Over five years, Finished Goods peaked at $640.0 million in Q3 2015 and troughed at $280.0 million in Q3 2014.
  • The 5-year median for Finished Goods is $485.0 million (2013), against an average of $479.5 million.
  • Year-over-year, Finished Goods plummeted 41.42% in 2014 and then skyrocketed 128.57% in 2015.
  • A 5-year view of Finished Goods shows it stood at $547.0 million in 2012, then dropped by 11.33% to $485.0 million in 2013, then decreased by 29.69% to $341.0 million in 2014, then soared by 37.54% to $469.0 million in 2015, then rose by 18.55% to $556.0 million in 2016.
  • Per Business Quant, the three most recent readings for ABBV's Finished Goods are $556.0 million (Q2 2016), $552.0 million (Q1 2016), and $469.0 million (Q4 2015).